Atraumatic bilateral femur fracture in long-term bisphosphonate use

Orthopedics

Volumn 33, Issue 12, 2010, Pages

  Yli Kyyny, Tero T ^a   Tamminen, Inari ^a   Kröger, Heikki ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

AGED; BONE BIOPSY; BONE MARROW BIOPSY; BONE RADIOGRAPHY; BONE TURNOVER; CASE REPORT; CORTICAL BONE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR SHAFT FRACTURE; FOLLOW UP; FRACTURE HEALING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAMEDULLARY NAILING; LEG PAIN; LETTER; OSTEOID OSTEOMA; OSTEOPENIA; CHEMICALLY INDUCED DISORDER; FEMUR FRACTURE; LONGITUDINAL STUDY; MULTIPLE TRAUMA; NOTE; OSTEOPOROSIS; OSTEOSYNTHESIS;

AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FEMORAL FRACTURES; FRACTURE FIXATION, INTERNAL; HUMANS; LONGITUDINAL STUDIES; MULTIPLE TRAUMA; OSTEOPOROSIS;

EID: 78651370389     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20101021-37     Document Type: Letter

References (3)

1. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy [published online ahead of print December 14, 2004]. J Clin Endocrinol Metab. 2005; 90(3):1294-1301.
2. Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med. 2008; 358(12):1304-1306. (Pubitemid 351439247)
3. Lee P, Seibel MJ. More on atypical fractures of the femoral diaphysis. N Engl J Med. 2008; 359(3):317; author reply 317-318. (Pubitemid 352008465)